第六章 結論與建議
第二節 建議
鑒於蝦紅素優異的抗氧化活性，對激烈運動或連續體能活動造成的過度疲累，
有顯著的氧化壓力防禦功效，可作為競技運動員及高競爭職場人員長期服用的健 康促進劑。
因此，未來的研究方向，建議分析蝦紅素對運動誘導的發炎、肌肉傷害指標 與心率、血管彈力等身心壓力指標，探討蝦紅素對於缺血再灌注等生理壓力因子 的調適性(adaptogen)功能。
54
參考文獻
一、中文文獻
林天送（2012）。自由基大革命。台北市，健康文化事業股份有限公司。
林志陵 & 曾正（2006）。生物化學一點通。台北市，合記圖書出版社。
翁玉青（2011）。抗氧化的威力。台中市。沐康健康管理顧問有限公司。
喬長誠（2006）。超級抗氧化劑蝦紅素。台北市，元氣齋出版社。
鄭榮梁、魏耀揮、趙崇義、黃中洋 & 陳建村（2013）。自由基生物醫學。新北 市。藝軒圖書出版社。
林天送（2008）。自由基化學與醫學。科學發展，432：48-53
林勁宏（2000），運動與脂質氧化傷害。中華體育，第十三卷第四期。
姚承義（1998）。β-胡蘿蔔素對消除運動氧化壓力的探討。中華體育季刊, 12(3), 101-109.
梁俊煌(2006)，運動訓練對人體體內自由基產生及抗氧化酵素之影響。嘉南學報，
第三十二期：433－442,
陳志強、任璐、王昌祿 & 楊輝（2008）。蝦青素對四氧嘧啶致糖尿病小鼠降血 糖作用研究。天然產物研究與開發, 20(6), 1064-1065.
曾郁 & 許美智（2009）。蝦紅素對運動表現之影響。大專體育, (105), 144-150.
葉姿劭 & 許美智（2010）。脂質轉運蛋白與耐力運動表現的關係。中華體育季 刊,24(1), 33-44.
廖威彰（2000）。從自由基的觀點來談運動與老化。中華體育第十三卷,第四期 劉婉君、洪啓智、張哲銘、黃尚志 & 陳鴻鈞（2010）。尿酸與腎臟病。內科學
誌,21(3), 197-203.
劉敏、胡嘉想、秦光和、景簫 & 王偉（2008）。蝦青素的毒理學安全性評價。
毒理學雜誌, 22(3), 244-246.
羅惠齡 & 劉新裕（2004）。自由基與抗氧化酵素。藥用植物資源之開發與利用 112：21-25。
55
二、英文文獻
Alessio, H.M. (1993). Exercise-induced oxidative stress. Medicine and Science in Sport and Exercise, 25 (2): 218-224.
Ambati, R. R., Phang, S. M., Ravi, S., & Aswathanarayana, R. G. (2014). Astaxanthin:
Sources, extraction, stability, biological activities and its commercial applications—A review. Marine drugs, 12(1), 128-152.
Ames, B. N., Shigrnaga, M. K., & Hagen, T. M. (1993). Oxidant, antioxidants and the degenerative disease of aging. Proceedings of the National Academy of Science of the Unite States of American, 90, 7915-7922.
Aoi, W., Naito, Y., Sakuma, K., Kuchide, M., Tokuda, H., Maoka, T. ... & Yoshikawa, T. (2003). Astaxanthin limits exercise-induced skeletal and cardiac muscle damage in mice. Antioxidants and Redox Signaling, 5(1), 139-144.
Aoi, W., Naito, Y., Takanami, Y., Ishii, T., Kawai, Y., Akagiri, S. ... & Yoshikawa, T.
(2008). Astaxanthin improves muscle lipid metabolism in exercise via inhibitory effect of oxidative CPT I modification. Biochemical and biophysical research communications, 366(4), 892-897.
Balcerczyk, A., Gajewska, A., Macierzyńska-Piotrowska, E., Pawelczyk, T., Bartosz, G., & Szemraj, J. (2014). Enhanced antioxidant capacity and anti-ageing
biomarkers after diet micronutrient supplementation.
Molecules, 19(9), 14794-14808.
Baralic, I., Djordjevic, B., Dikic, N., Kotur‐Stevuljevic, J., Spasic, S., Jelic‐Ivanovic, Z. ... & Pejic, S. (2013). Effect of astaxanthin supplementation on paraoxonase 1 activities and oxidative stress status in young soccer players. Phytotherapy Research, 27(10), 1536-1542.
Bejma, J. & Ji, L.L. (1999). Aging and acute exercise enhance free radical generation in rat skeletal muscle. Journal of Applied Physiology, 87(1): 465-470.
Bloomer, R. J., Fry, A., Schilling, B., Chiu, L., Hori, N., & Weis, L. (2005).
Astaxanthin supplementation does not attenuate muscle injury following eccentric exercise in resistance-trained men. International journal of sport nutrition and exercise metabolism, 15(4), 401.
Bouzid, M. A., Hammouda, O., Matran, R., Robin, S., & Fabre, C. (2014). Changes in oxidative stress markers and biological markers of muscle injury with aging at rest
56
and in response to an exhaustive exercise. PLoS One, 9(3), e90420.
Camera, E., Mastrofrancesco, A., Fabbri, C., Daubrawa, F., Picardo, M., Sies, H., &
Stahl, W. (2009). Astaxanthin, canthaxanthin and β‐carotene differently affect UVA‐induced oxidative damage and expression of oxidative stress‐responsive enzymes. Experimental dermatology, 18(3), 222-231.
Capelli, B. (2007). Natural Astaxanthin：King of the Carotenoids. Japan. Cyanotech Corporation. ISBN-13: 978-0-9792353-0-6. ISBN-10: 0-9792353-0-8
Cassidy, A., O'Reilly, É . J., Kay, C., Sampson, L., Franz, M., Forman, J. P. ... & Rimm, E. B. (2011). Habitual intake of flavonoid subclasses and incident hypertension in adults. The American journal of clinical nutrition, 93(2), 338-347.
Chen, Y. Y., Lee, P. C., Wu, Y. L., & Liu, L. Y. (2015). In Vivo Effects of Free Form Astaxanthin Powder on Anti-Oxidation and Lipid Metabolism with
High-Cholesterol Diet. PloS one, 10(8), e0134733.
Child, R., Brown, S., Day, S., Donnelly, A., Roper, H. & Saxton, J. (1999). Change in indices of antioxidant status, lipid peroxidation and inflammation in human skeletal muscle after eccentric muscle actions. The Biochemical Society and the Medical Research Society, 96: 105-115.
Child, R., Brown, S., Day, S., Donnelly, A., Roper, H., & Saxton, J. (1999). Changes in indices of antioxidant status, lipid peroxidation and inflammation in human skeletal muscle after eccentric muscle actions. Clinical Science, 96, 105-115.
Choi, H. D., Kim, J. H., Chang, M.J., Kyu-Youn, Y., & Shin, W.G. (2011). Effects of astaxanthin on oxidative stress in overweight and obese adults. Phytotherapy research, 25(12), 1813-1818.
Choi, H. D., Youn, Y. K., & Shin, W. G. (2011). Positive effects of astaxanthin on lipid profiles and oxidative stress in overweight subjects. Plant foods for human nutrition, 66(4), 363-369.
Cort, A., Ozturk, N., Akpinar, D., Unal, M., Yucel, G., Ciftcioglu, A. ... & Aslan, M.
(2010). Suppressive effect of astaxanthin on retinal injury induced by elevated intraocular pressure. Regulatory Toxicology and Pharmacology, 58(1), 121-130.
Diaz, M. N., Frei, B., Vita, J. A., & Keaney Jr, J. F. (1997). Antioxidants and
atherosclerotic heart disease. New England Journal of Medicine, 337(6), 408-416.
Fassett, R. G., & Coombes, J. S. (2011). Astaxanthin: a potential therapeutic agent in cardiovascular disease. Marine drugs, 9(3), 447-465.
57
Finkler, M., Hochman, A., Pinchuk, I., & Lichtenberg, D. (2016). In Healthy Young Men, a Short Exhaustive Exercise Alters the Oxidative Stress Only Slightly, Independent of the Actual Fitness. Oxidative Medicine and Cellular
Longevity, 2016.
Franceschelli, S., Pesce, M., Ferrone, A., De Lutiis, M. A., Patruno, A., Grilli, A. ... &
Speranza, L. (2014). Astaxanthin Treatment Confers Protection against Oxidative Stress in U937 Cells Stimulated with Lipopolysaccharide Reducing O 2−
Production. PloS one, 9(2), e88359.
Fuchs, J. (1998). Potentials and limitations of the natural antioxidants RRR-alpha-tocopherol, L-ascorbic acid and β-carotene in cutaneous photoprotection.Free Radical Biology and Medicine, 25(7), 848-873.
Goto, S., Kogure, K., Abe, K., Kimata, Y., Kitahama, K., Yamashita, E., & Terada, H.
(2001). Efficient radical trapping at the surface and inside the phospholipid membrane is responsible for highly potent antiperoxidative activity of the carotenoid astaxanthin. Biochimica et Biophysica Acta
(BBA)-Biomembranes, 1512(2), 251-258.
Gutteridge, J. M., & Halliwell, B. (1990). The measurement and mechanism of lipid peroxidation in biological systems. Trends in biochemical sciences, 15(4), 129-135.
Halliwell, B., & Chirico, S. (1993). Lipid peroxidation: its mechanism, measurement, and significance. The American journal of clinical nutrition, 57(5), 715S-724S.
Halliwell, B., & Gutteridge, J. (1984). Oxygen toxicity, oxygen radicals, transition metals and disease. Biochemical journal, 219(1), 1.
Harman, D. (1955). Aging: a theory based on free radical and radiation chemistry.
Hermansen, L., Maehlum, S., Pruett, E. D. R., Vaage, O., Waldum, H., & Wessel-Aas, T. (1975). Lactate removal at rest and during exercise. In Metabolic adaptation to prolonged physical exercise, 101-105
Higuera-Ciapara, I., Felix-Valenzuela, L., & Goycoolea, F. M. (2006). Astaxanthin: a review of its chemistry and applications. Critical reviews in food science and nutrition, 46(2), 185-196.
Hussein, G., Nakamura, M., Zhao, Q., Iguchi, T., Goto, H., Sankawa, U., & Watanabe, H. (2005). Antihypertensive and neuroprotective effects of astaxanthin in
experimental animals. Biological and Pharmaceutical Bulletin, 28(1), 47-52
58
Hussein, G., Nakagawa, T., Goto, H., Shimada, Y., Matsumoto, K., Sankawa, U., &
Watanabe, H. (2007). Astaxanthin ameliorates features of metabolic syndrome in SHR/NDmcr-cp. Life sciences, 80(6), 522-529.
Ikeuchi, M., Koyama, T., Takahashi, J., & Yazawa, K. A. Z. U. N. A. G. A. (2007).
Effects of astaxanthin in obese mice fed a high-fat diet. Bioscience, biotechnology, and biochemistry, 71(4), 893-899.
Iwabayashi, M., et al., （2009）. Efficacy and safety of eight-week treatment with astaxanthin in individuals screened for increased oxidative stress burden.
Anti-Aging Medicine 6 (4): 15-21
Iwamoto, T., Hosoda, K., Hirano, R., Kurata, H., Matsumoto, A., Miki, W.... & Kondo, K. (2000). Inhibition of low-density lipoprotein oxidation by astaxanthin. Journal of atherosclerosis and thrombosis, 7(4), 216-222.
Jenkins, R. R., (1988). Free radical chemistry: relationship to exercise. Sports Medicine, 5(2), 156-170.
Johnson, P. (2002). Antioxidant enzyme expression in health and disease: Effects of exercise and hypertension. Comparative Biochemistry and Physiology, 133, 493-505.
Jyonouchi, H., Sun, S., Tomita, Y., & Gross, M. D. (1995). Astaxanthin, a carotenoid without vitamin A activity, augments antibody response in cultures including T-helper cell clones and suboptimal doses of antigen. The Journal of
nutrition, 125(10), 2483.
Karakaya, S. (2004). Bioavailability of phenolic compounds. Critical reviews in food science and nutrition, 44(6), 453-464.
Kazzaz, J. A., Xu, J., Palaia, T. A., Mantell, L., Fein, A. M., & Horowitz, S. (1996).
Cellular Oxygen Toxicity Oxidant Injury without Apoptosis. Journal of Biological Chemistry, 271(25), 15182-6.
Kiko T., Nakagawa K., Satoh A., Tsuduki T., Furukawa K., Arai H., et al. (2012) Amyloid b Levels in Human Red Blood Cells. PLOS ONE 7(11)
Klinkenberg, L. J., Haenen, G. R., Bast, A., van Loon, L. J., van Dieijen-Visser, M. P.,
& Meex, S. J. (2013). Effect of Antioxidant Supplementation on Exercise-Induced Cardiac Troponin Release in Cyclists: A Randomized Trial. PloS one, 8(11), e79280.
Knez, W. L., Jenkins, D. G., & Coombes, J. S. (2007). Oxidative stress in half and full
59
Ironman triathletes. Medicine and science in sports and exercise, 39(2), 283.
Krajcovicová-Kudlácková, M., Dusinská, M., Valachovicová, M., Blazicek, P., &
Paukova, V. (2006). Products of DNA, protein and lipid oxidative damage in relation to vitamin C plasma concentration. Physiol Res, 55(1), 227-31.
Kritchevsky, S. B. (1999). β -Carotene, carotenoids and the prevention of coronary heart disease. The Journal of nutrition, 129(1), 5-8.
Kupcinskas L., et al., （2008）Efficacy of the natural antioxidant astaxanthin in the treatment of functional dyspepsia in patients with or without Helicobacter pylori infection: A prospective, randomized, double blind, and placebo-controlled study.
Phytomedicine 15, p391-399
Lander, H. M. (1997). An essential role for free radicals and derived species in signal transduction. The FASEB journal, 11(2), 118-124.
Leite, M. F., de Lima, A. M., Massuyama, M. M., & Otton, R. (2010). Astaxanthin restores the enzymatic antioxidant profile in salivary gland of alloxan-induced diabetic rats. Archives of oral biology, 55(7), 479-485.
Lignell, A. (2001). Medicament for improvement of duration of muscle function or treatment of muscle disorders or diseases. U.S. Patent No. 6,245,818. Washington, DC: U.S. Patent and Trademark Office.
Liu X., and Osawa T. (2009). Astaxanthin Protects Neuronal Cells against Oxidative Damage and Is a Potent Candidate for Brain Food. Food Factors for Health Promotion. Forum Nutr. Basel, Karger, 61, 129–135
Lu, Y., Xie, T., He, X. X., Mao, Z. F., Jia, L. J., Wang, W. P., ... & Liu, L. M. (2015).
Astaxanthin rescues neuron loss and attenuates oxidative stress induced by amygdala kindling in adult rat hippocampus. Neuroscience letters, 597, 49-53.
Li, X. D., Sun, G. F., Zhu, W. B., & Wang, Y. H. (2014). Effects of high intensity exhaustive exercise on SOD, MDA, and NO levels in rats with knee
osteoarthritis. Genetics and molecular research: GMR, 14(4), 12367-12376.
Malmstena, C. L., & Lignellb, A. (2008). Dietary Supplementation with
Astaxanthin-Rich Algal Meal Improves Strength Endurance–A Double Blind Placebo Controlled Study on Male Students. Carotenoid Sci, 13, 20-22.
Martin, H. D., Ruck, C., Schmidt, M., Sell, S., Beutner, S., Mayer, B., & Walsh, R.
(1999). Chemistry of carotenoid oxidation and free radical reactions. Pure and applied chemistry, 71(12), 2253-2262.
60
McArdle, F., Pattwell, D. M., Vasilaki, A., MaArdle, A., & Jackson, M. J. (2005).
Intracellular generation of reactive oxygen species by contracting skeletal muscle cells. Free Radical Biological Medicine, 39, 651-657.
McNulty, H. P., Byun, J., Lockwood, S. F., Jacob, R. F., & Mason, R. P. (2007).
Differential effects of carotenoids on lipid peroxidation due to membrane interactions: X-ray diffraction analysis. Biochimica et Biophysica Acta (BBA)-Biomembranes, 1768(1), 167-174.
Meyer, A. S., & Isaksen, A. (1995). Application of enzymes as food antioxidants. Trends in Food Science & Technology, 6(9), 300-304.
Miki, W. (1991). Biological functions and activities of animal carotenoids. Pure and Applied Chemistry, 63(1), 141-146.
Moncada S., Palmer R.M.J., Higgs E.A. (1991). Nitric oxide: physiology, pathophysiology and pharmacology. Pharmacol. Rev., 43, 109–141.
Muller, F. L., Lustgarten, M. S., Jang, Y., Richardson, A., & Van Remmen, H. (2007).
Trends in oxidative aging theories. Free Radical Biology and Medicine, 43(4), 477-503.
Murillo, E. (1992). [Hypercholesterolemic effect of canthaxanthin and astaxanthin in rats]. Archivos Latinoamericanos de nutrición, 42(4), 409-413.
Nishida, Y., Yamashita, E., & Miki, W. (2007). Quenching activities of common hydrophilic and lipophilic antioxidants against singlet oxygen using
chemiluminescence detection system. Carotenoid Science, 11, 16-20.
O'Connor, I., & O'Brien, N. (1998). Modulation of UVA light-induced oxidative stress by β-carotene, lutein and astaxanthin in cultured fibroblasts. Journal of
dermatological science, 16(3), 226-230.
Ohshima, H., Gilibert, I., & Bianchini, F. (1999). Induction of DNA strand breakage and base oxidation by nitroxyl anion through hydroxyl radical production. Free Radical Biology and Medicine, 26(9), 1305-1313.
Okada Y, Ishikura M, Maoka T. (2009). Bioavailability of astaxanthin in
Haematococcus algal extract: the effects of timing of diet and smoking habits.
Biosci Biotechnol Biochem 73:1928-1932.
Otsuka, T., Shimazawa, M., Nakanishi, T., Ohno, Y., Inoue, Y., Tsuruma, K. ... & Hara, H. (2013). The Protective Effects of a Dietary Carotenoid, Astaxanthin, Against Light-Induced Retinal Damage. Journal of pharmacological sciences, 123(3),
61
209-218.
Packer, L., & Colman, C. (1999). The Antioxidant miracle: your complete plan for total health and healing. Wiley.
Pashkow, F. J., Watumull, D. G., & Campbell, C. L. (2008). Astaxanthin: a novel potential treatment for oxidative stress and inflammation in cardiovascular disease. The American journal of cardiology, 101(10), S58-S68.
Piermarocchi, S., Saviano, S., Parisi, V., Tedeschi, M., Panozzo, G., Scarpa, G. ... &
Lo Giudice, G. (2012). Carotenoids in Age-related Maculopathy Italian Study (CARMIS): two-year results of a randomized study. European journal of ophthalmology, 22(2), 216.
Perricone, N. V., (2011). Forever Young: The Science of Nutrigenomics for Glowing, Wrinkle-Free Skin and Radiant Health at Every Age. Pocket Books
Polotow, T. G., Vardaris, C. V., Mihaliuc, A. R., Gonçalves, M. S., Pereira, B., Ganini, D., & Barros, M. P. (2014). Astaxanthin Supplementation Delays Physical
Exhaustion and Prevents Redox Imbalances in Plasma and Soleus Muscles of Wistar Rats. Nutrients, 6(12), 5819-5838.
Przedborski, S., Jackson-Lewis, V., Yokoyama, R., Shibata, T., Dawson, V. L., &
Dawson, T. M. (1996). Role of neuronal nitric oxide in 1- methyl- 4-phenyl - 1, 2, 3, 6-tetrahydropyridine (MPTP) - induced dopaminergic neurotoxicity.
Proceedings of the National Academy of Sciences, 93(10), 4565-4571.
Qiu, X., Fu, K., Zhao, X., Zhang, Y., Yuan, Y., Zhang, S. ... & Guo, H. (2015).
Protective effects of astaxanthin against ischemia/reperfusion induced renal injury in mice. J. Transl. Med, 13, 28.
Reckelhoff, J. F., & Fortepiani, L. A. (2004). Novel mechanisms responsible for postmenopausal hypertension. Hypertension, 43, 918-923.
Rengel, D., Dıez-Navajas, A., Serna-Rico, A., Veiga, P., Muga, A., & Milicua, J. C. G.
(2000). Exogenously incorporated ketocarotenoids in large unilamellar vesicles.
Protective activity against peroxidation. Biochimica et Biophysica Acta (BBA)-Biomembranes, 1463(1), 179-187.
Res, P. T., Cermak, N. M., Stinkens, R., Tollakson, T. J., Haenen, G. R., Bast, A., &
Van Loon, L. J. (2013). Astaxanthin supplementation does not augment fat use or improve endurance performance. Med Sci Sports Exerc, 45(6), 1158-1165.
Scandalios, J. G. (2005). Oxidative stress: molecular perception and transduction of
62
signals triggering antioxidant gene defenses. Brazilian Journal of Medical and Biological Research, 38(7), 995-1014.
Sies, H. (1994). Strategies of antioxidant defense. In EJB Reviews 1993 (pp. 101-107).
Springer Berlin Heidelberg.
Sila, A., Ghlissi, Z., Kamoun, Z., Makni, M., Nasri, M., Bougatef, A., & Sahnoun, Z.
(2015). Astaxanthin from shrimp by-products ameliorates nephropathy in diabetic rats. European journal of nutrition, 54(2), 301-307.
Smith, J. A. (1995). Exercise, training and red blood cell turnover. Sports Medicine, 19(1), 9-31.
Strand, R. (2013). What your doctor doesn't know about nutritional medicine may be killing you. Thomas Nelson Inc.
Takahashi, J., Tsukahara, H., & Minato, S. (2004). Toxicological studies of astaxanthin from Haematococcus pluvialis—Ames test, oral single dose and 90-days sub chronic toxicity studies in rats. J Clin Therap Med, 20, 867-881.
Terazawa, S., Nakajima, H., Shingo, M., Niwano, T., & Imokawa, G. (2012).
Astaxanthin attenuates the UVB‐induced secretion of prostaglandin E2 and interleukin‐8 in human keratinocytes by interrupting MSK1 phosphorylation in a ROS depletion–independent manner. Experimental dermatology, 21(s1), 11-17.
Tripathi, D. N., & Jena, G. B. (2009). Intervention of astaxanthin against cyclophosphamide-induced oxidative stress and DNA damage: a study in mice.Chemico-biological interactions, 180(3), 398-406.
Trekli, M. C., Riss, G., Goralczyk, R., & Tyrrell, R. M. (2003). Beta-carotene suppresses UVA-induced HO-1 gene expression in cultured FEK4. Free Radical Biology and Medicine, 34(4), 456-464.
Tsai, L. Y., Lee, K. T., Tsai, S. M., Lee, S. C., & Yu, H. S. (1993). Changes of lipid peroxide levels in blood and liver tissue of patients with obstructive
jaundice. Clinica chimica acta, 215(1), 41-50.
Tso, M. O., & Lam, T. T. (1996). Method of retarding and ameliorating central
nervous system and eye damage. U.S. Patent No. 5,527,533. Washington, DC: U.S.
Patent and Trademark Office.
Turkez, H., Geyikoglu, F., & Yousef, M. I. (2013). Beneficial effect of astaxanthin on 2, 3, 7, 8-tetrachlorodibenzo-p-dioxin-induced liver injury in rats. Toxicology and industrial health, 29(7), 591-599.
63
Urso, M. L. & Clarkson, P. M. (2003). Oxidative stress, exercise, and antioxidant supplementation. Toxicology. 189, 41-54.
Ursoniu, S., Sahebkar, A., Serban, M. C., & Banach, M. (2015). Lipid profile and glucose changes after supplementation with astaxanthin: a systematic review and meta-analysis of randomized controlled trials. Archives of medical science:
AMS, 11(2), 253.
Veal, E. A., Day, A. M., & Morgan, B. A. (2007). Hydrogen peroxide sensing and signaling. Molecular cell, 26(1), 1-14.
Wadstrom, T., and Alejung, P. (2001) Oral preparation for the prophylactic and therapeutic treatment of Helicobacter sp. infection. U.S. Patent No. 6,262,316.
Wolf, A. M., Asoh, S., Hiranuma, H., Ohsawa, I., Iio, K., Satou, A. ... & Ohta, S.
(2010). Astaxanthin protects mitochondrial redox state and functional integrity against oxidative stress. The Journal of nutritional biochemistry, 21(5), 381-389.
Wang, X., Zhao, H., Shao, Y., Wang, P., Wei, Y., Zhang, W. ... & Zhang, Z. (2014).
Nephroprotective effect of astaxanthin against trivalent inorganic arsenic-induced renal injury in wistar rats. Nutrition research and practice, 8(1), 46-53.
Wong, S. H., Knight, J. A., Hopfer, S. M., Zaharia, O., Leach, C. N., & Sunderman, F.
(1987). Lipoperoxides in plasma as measured by liquid-chromatographic separation of malondialdehyde-thiobarbituric acid adduct. Clinical Chemistry, 33(2), 214-220.
Xu, J., Gao, H., Zhang, L., Chen, C., Yang, W., Deng, Q. ... & Huang, F. (2014). A combination of flaxseed oil and astaxanthin alleviates atherosclerosis risk factors in high fat diet fed rats. Lipids in health and disease, 13(1), 1-7
Yamashita, E. (2005). The effects of a dietary supplement containing astaxanthin on skin condition. Food Style 21, 9(9), 72.
Yamashita, E. (2013). Astaxanthin as a medical food. Functional Foods in Health and Disease, 3(7), 254-258.
Yanai, H., Ito, K., Yoshida, H., & Tada, N. (2008). Antihypertensive effects of astaxanthin. Integrated blood pressure control, 1, 1:3
Ye Q. Y., Huang B. X., Zhang X. D., Zhu Y. G. and Chen X. C. (2012). Astaxanthin protects against MPP+-induced oxidative stress in PC12 cells via the HO-1/
NOX2 axis. BMC Neuroscience, 13:156
Yoshida, H., Yanai, H., Ito, K., Tomono, Y., Koikeda, T., Tsukahara, H., & Tada, N.
64
(2010). Administration of natural astaxanthin increases serum HDL-cholesterol and adiponectin in subjects with mild hyperlipidemia. Atherosclerosis, 209(2), 520-523.
Yuan, J. P., Peng, J., Yin, K., & Wang, J. H. (2011). Potential health‐promoting effects of astaxanthin: a high‐value carotenoid mostly from microalgae. Molecular nutrition & food research, 55(1), 150-165.
Zhao, Z. W., Cai, W., Lin, Y. L., Lin, Q. F., Jiang, Q., Lin, Z., & Chen, L. L. (2010).
Ameliorative effect of astaxanthin on endothelial dysfunction in
streptozotocin-induced diabetes in male rats. Arzneimittel-Forschung, 61(4), 239-246.
65
附錄
一、人體研究倫理委員會同意書
66 二、受試者須知
受試者須知
先前研究指出攝取蝦紅素（雨生紅球藻萃取）有益健康，相關文獻表明可能 效果如預防年齡相關之腦、神經、眼睛、心血管及代謝疾病（詳如宣傳單），本 研究旨在探討增補蝦紅素對年輕族群的健康及氧化壓力與運動表現的影響。
本研究受試者採交叉實驗，每位受試者需增補蝦紅素及安慰劑各5週，中間停用 5週；每位受試者於首次運動測試後，隨機區分為增補劑或安慰劑組，食用實驗 品5週，第6至10週暫停攝食，第11週起互換實驗組別繼續食用實驗品，並於 第15週實施後測。
一、每位受試者需在增補前、增補滿5週、中間停用5週再次增補時及再次增補 滿5週接受檢測，檢測項目
1. 一般身體量測如血壓、脈搏、身高、體重等身體組成。
2. 一般血液生化之總膽固醇、高、低密度脂蛋白、三酸甘油酯、血糖、尿酸 及總抗氧化能力與超氧化物歧化酶、氧化壓力指標之丙二醛。
3. 執行運動至力竭測試，觀察運動前後三酸甘油酯、血糖、尿酸值變化。
二、受試者攝食之實驗品如下
1. 增補劑組：每日早餐及晚餐後增補蝦紅素（萃取自雨生紅球藻）膠囊，每次 增補劑量為1顆（8mg），每日總計2顆（16mg），連續增補8週。
2. 安慰劑組：增補方式同實驗組，增補食品級麥芽糊精膠囊。
三、聲明事項
1. 本試驗增補劑與安慰劑，均採用合格的膳食補充品，目前無過敏等不良反應，
實驗期間若發生過敏反應例如全身性蕁麻疹，請立即停止增補，並請通知研 究人員。
2. 運動測試時，若身體感到極度不舒服、嚴重呼吸困難、胸悶、胸痛，請立即 通知研究人員，將即時加強健康照護。
感謝您參與本次受試者說明，您的參與對本研究有極大的意義與貢獻，謹此 表達我們最深的謝意！後續實驗期間，若您對實驗有任何疑慮，請隨時提供寶貴 意見共同討論，並有權終止參與實驗。本次研究完成後，您可以透過實驗結果，
瞭解自身的健康狀況與抗氧化能力。敬請填寫健康狀況調查表，以認定您的身體 狀況是否適合參與此研究計畫。
研究單位：國立台北護理健康大學 指導教授：郭堉圻 博士
研 究 生：郭蕙蘭 電 話：